Bourgoin, Pierre http://orcid.org/0000-0001-7713-8153
Lecomte, Jules
Oualha, Mehdi
Berthomieu, Lionel
Pereira, Tony
Davril, Emeline
Lamoureux, Fabien
Joram, Nicolas
Chenouard, Alexis
Duflot, Thomas http://orcid.org/0000-0002-8730-284X
Funding for this research was provided by:
ORION PHARMA, Espoo, Finland
Article History
Accepted: 11 December 2022
First Online: 11 January 2023
Change Date: 8 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40262-023-01218-6
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Pierre Bourgoin’s institution received funding from Orion Pharma, Espoo, Finland. Jules Lecomte, Mehdi Oualha, Lionel Berthomieu, Tony Pereira, Emeline Davril, Fabien Lamoureux, Nicolas Joram, Alexis Chenouard<sub>,</sub> and Thomas Duflot declare they have no potential conflicts of interest.
: The study was approved by an independent review board (CPP IV Ile de France, reference 018-A02042-53). This study was conducted in accordance with the Helsinki Declaration.
: Parents provided written informed consent during the inclusion visit.
: Not applicable.
: Not applicable.
: All data generated or analyzed during this study are included in this published article and its online resources. Feel free to contact the corresponding author if needed.
: PB and TD: Conceptualization, Data Curation, Analysis, Funding acquisition, Investigation, Writing, editing and Reviewing the manuscript. JL: Data curation, Analysis. MO, LB, NJ and AC: local investigators, Reviewing of the manuscript. TP, ED, FL: laboratory investigations.